-
-
-
-
-
-
-
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
-
-
-
-
-
-
-
Onconetix names David White as CEO, adds Sammy Dorf to board
-
-
-
-
-
-
-
Onconetix raises $12.9 million, settles Veru debt, ends Ocuvex merger
-
-
-
-
-
-
-
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
-
-
-
-
-
-
-
Onconetix (ONCO) signs loi for potential merger with Ocuvex Therapeutics
-
-
-
-
-
-
-
Onconetix (ONCO) Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing
-
-
-
-
-
-
-
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds
-
1,184,282 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

